BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22136658)

  • 1. Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.
    Villani M; Tiscia GL; Margaglione M; Colaizzo D; Fischetti L; Vergura P; Grandone E
    J Thromb Haemost; 2012 Feb; 10(2):223-8. PubMed ID: 22136658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
    Simioni P; Tormene D; Luni S; Caldato M; Girolami A
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
    Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
    Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
    Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
    J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
    Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
    Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.
    Samama MM; Rached RA; Horellou MH; Aquilanti S; Mathieux VG; Plu-Bureau G; Elalamy I; Conard J
    Br J Haematol; 2003 Oct; 123(2):327-34. PubMed ID: 14531916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
    J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
    Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
    J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals.
    Lim MY; Deal AM; Kim S; Musty MD; Conard J; Simioni P; Dutrillaux F; Eid SS; Middeldorp S; Halbmayer WM; Boneu B; Moia M; Moll S
    Eur J Haematol; 2016 Oct; 97(4):353-60. PubMed ID: 26773706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS; Miletich JP; Goldhaber SZ; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2001 Jan; 37(1):215-8. PubMed ID: 11153741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women.
    Grandone E; Colaizzo D; Tiscia G; Vergura P; Cappucci F; Greco L; Margaglione M; Martinelli P;
    J Thromb Haemost; 2011 Mar; 9(3):496-501. PubMed ID: 21232003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
    J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism.
    Kovac M; Mitic G; Mikovic Z; Djordjevic V; Savic O; Mandic V; Rakicevic LJ; Antonijevic N; Radojkovic D
    Gynecol Obstet Invest; 2010; 69(4):233-238. PubMed ID: 20068329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.